Ally-Bridge-Group-Ny
AI_NATIVE detailed information: This accession holds the following tickers:[ "MRUS", "AXSM", "EWTX", "TRVI", "CNTA", "INSM", "SWTX", "TYRA", "MNMD", "TECX", "JANX", null, "GERN", "TARS", "KRRO", "WHWK", "PMN", "ATYR", null, "PRAX", "SLNO", "CNTX", "ELVN", "VRNA", "XENE", "BPMC", "CGON", "DNTH" ]
Filing Details
13F-HR • 2025-03-31
Filing Details
13F-HR • 2025-03-31- Report Date
- 2025-03-31
- Filing Date
- 2025-05-15
- Total Holdings
- 28
- Total Value
- 110931993
- Accession Number
- 0000950123-25-005586
- Form Type
- 13F-HR
- Manager Name
- Ally-Bridge-Group-Ny
Data Enrichment
93% identified26 identified2 unidentified
Holdings
28 positions • $110.9M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Shares:281.1K
Value:$12.4M
% of Portfolio:11.2% ($12.4M/$110.9M)
Shares:127.9K
Value:$6.6M
% of Portfolio:5.9% ($6.6M/$110.9M)
05464T904
Shares:50.0K
Value:$5.8M
% of Portfolio:5.3% ($5.8M/$110.9M)
Shares:95.6K
Value:$3.6M
% of Portfolio:3.3% ($3.6M/$110.9M)
Shares:243.1K
Value:$3.5M
% of Portfolio:3.2% ($3.5M/$110.9M)
Shares:390.1K
Value:$2.3M
% of Portfolio:2.1% ($2.3M/$110.9M)
Instrument | Shares | Other Manager | Value | % of Portfolio | ||
|---|---|---|---|---|---|---|
| 281.1K | YoY NEW(+281.1K) | All Managers (Combined) | $12.4M | 11.2% ($12.4M/$110.9M) | YoY NEW(+$12.4M) | |
| 139.1K | QoQ NEW(+139.1K) | All Managers (Combined) | $8.8M | 8.0% ($8.8M/$110.9M) | QoQ NEW(+$8.8M) | |
| 120.4K | All Managers (Combined) | $8.6M | 7.8% ($8.6M/$110.9M) | |||
| 72.1K | YoY NEW(+72.1K) | All Managers (Combined) | $8.4M | 7.6% ($8.4M/$110.9M) | YoY NEW(+$8.4M) | |
| 127.9K | YoY NEW(+127.9K) | All Managers (Combined) | $6.6M | 5.9% ($6.6M/$110.9M) | YoY NEW(+$6.6M) | |
| 74.2K | All Managers (Combined) | $6.6M | 5.9% ($6.6M/$110.9M) | |||
INSMED Inc(INSMcusip457669307) | 85.1K | All Managers (Combined) | $6.5M | 5.9% ($6.5M/$110.9M) | ||
(cusip05464T904)✕ | 50.0K | QoQ NEW(+50.0K) YoY NEW(+50.0K) | All Managers (Combined) | $5.8M | 5.3% ($5.8M/$110.9M) | QoQ NEW(+$5.8M) YoY NEW(+$5.8M) |
| 686.2K | YoY NEW(+686.2K) | All Managers (Combined) | $4.3M | 3.9% ($4.3M/$110.9M) | YoY NEW(+$4.3M) | |
| 95.6K | All Managers (Combined) | $3.6M | 3.3% ($3.6M/$110.9M) | |||
| 243.1K | YoY NEW(+243.1K) | All Managers (Combined) | $3.5M | 3.2% ($3.5M/$110.9M) | YoY NEW(+$3.5M) | |
| 169.8K | YoY NEW(+169.8K) | All Managers (Combined) | $3.3M | 3.0% ($3.3M/$110.9M) | YoY NEW(+$3.3M) | |
Merus N.V.(MRUScusipN5749R100) | 77.9K | All Managers (Combined) | $3.3M | 3.0% ($3.3M/$110.9M) | ||
GERON CORP(GERNcusip374163103) | 2.1M | All Managers (Combined) | $3.3M | 2.9% ($3.3M/$110.9M) | ||
| 132.3K | All Managers (Combined) | $3.2M | 2.9% ($3.2M/$110.9M) | |||
aTYR PHARMA INC(ATYRcusip002120202) | 777.0K | YoY NEW(+777.0K) | All Managers (Combined) | $2.3M | 2.1% ($2.3M/$110.9M) | YoY NEW(+$2.3M) |
| 132.2K | QoQ NEW(+132.2K) YoY NEW(+132.2K) | All Managers (Combined) | $2.3M | 2.1% ($2.3M/$110.9M) | QoQ NEW(+$2.3M) YoY NEW(+$2.3M) | |
| 69.6K | All Managers (Combined) | $2.3M | 2.1% ($2.3M/$110.9M) | |||
| 390.1K | All Managers (Combined) | $2.3M | 2.1% ($2.3M/$110.9M) | |||
| 102.7K | YoY NEW(+102.7K) | All Managers (Combined) | $2.3M | 2.0% ($2.3M/$110.9M) | YoY NEW(+$2.3M) |